Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Pages in category "Health care companies of the United States" The following 10 pages are in this category, out of 10 total. This list may not reflect recent changes .
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Health care companies by year of disestablishment (39 C) Hospital networks (9 C, 25 P) L. Health care company logos (16 F) M. Medical technology companies (8 C, 3 P)
This is a list of unicorn startup companies: In finance, a unicorn is a privately held startup company with a current valuation of US$1 billion or more. Notable lists of unicorn companies are maintained by The Wall Street Journal, [1] Fortune Magazine, [2] CNNMoney/CB Insights, [3] [4] TechCrunch, [5] PitchBook/Morningstar, [6] and Tech in Asia ...
In 2017, Bright Health acquired the marketing firm Spyder Trap, [9] and its founder became Bright Health's Chief Technology Officer. [10] In June 2017, the company raised an additional $160 million in Series B funding. [11] In September 2017, Forbes included Bright Health on a list of 25 "next billion-dollar startups". [12]
Pages in category "Health care companies based in New York (state)" The following 44 pages are in this category, out of 44 total. This list may not reflect recent changes .
Rank Year Purchaser Target Value (in billions USD) Value (adjusted for inflation) 1 2015 Pfizer: Allergan, plc: 160 206 In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation).